The board, whose members are appointed by Gov. Ron DeSantis, voted 6-3 to adopt the new standard of care. Five other board members did not attend the meeting.
The Florida Board of Osteopathic Medicine also voted to restrict gender-affirming care for new patients Nov. 4, with the exception of individuals participating in clinical trials.
Florida’s medical board is the first in the country to take such an action. The decision means physicians who offer gender-affirming care could be at risk of losing their licenses.
Read the full article here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
